This is a profile image of Alex Monnard

Alex Monnard

PartnerGeneva

Partner within the Life Sciences Practice and global leader of McKinsey biosimilars practice

Alex is a partner in our Geneva office. As a global leader of McKinsey’s biosimilars work and the head of our medical devices unit, he is a driving force in assisting clients with business-building, transformation, marketing and sales, strategy, and M&A for large and mid-sized life sciences companies worldwide.

Before joining McKinsey, Alex completed a PhD in Mathematics at the Swiss Institute of Technology. He brings a wealth of knowledge to his clients, applying his expertise to guide them towards success in the life sciences arena.

PUBLISHED WORK

Three imperatives for R&D in biosimilars building,” McKinsey & Company, August 2022

How medtech companies can create value with new business building,” McKinsey & Company, January 2022

An inflection point for biosimilars,” McKinsey & Company, June 2021

Understanding the opportunity in Japan’s biosimilar market,” McKinsey & Company, September 2019

EDUCATION

Swiss Federal School of Technology, Switzerland
PhD, mathematics

Swiss Federal School of Technology, Switzerland
MA, mathematics